Primary FDA-Approved Indications
Keflex (Cephalexin) is widely used in pediatric practice for skin infections, bone infections, urinary tract infections. It is FDA-approved for use in all pediatric ages with typical dosing of 25-50 mg/kg/day divided into 2-4 doses. Clinical evidence supports its safety and efficacy when used as directed.
Skin and Soft Tissue Infections (e.g., Impetigo, Cellulitis)
FDA ApprovedCephalexin is a first-line agent for uncomplicated skin infections caused by Streptococcus pyogenes or MSSA (non-MRSA).
Efficacy Data
Evidence Sources
Streptococcal Pharyngitis (Strep Throat)
FDA ApprovedAn alternative to penicillin/amoxicillin for children with non-anaphylactic penicillin allergy; effective against group A strep.
Efficacy Data
Evidence Sources
Urinary Tract Infections (Cystitis)
FDA ApprovedCephalexin is commonly used for uncomplicated lower UTIs in children when susceptibility is confirmed or likely.